Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2010-6-17
pubmed:abstractText
Interleukin (IL)-2/IL-2R signalling promotes proliferation and survival of activated T cells and has an essential non-redundant role in the production of regulatory T cells. Associations with different autoimmune diseases of polymorphisms in a linkage disequilibrium block in which the IL2/IL21 genes map (4q27), and also in genes encoding the IL2RA and IL2RB subunits (located in 10p15 and 22q13, respectively), were identified through genome-wide studies. Polymorphisms in these three genes were studied in 430 multiple sclerosis (MS) patients and in 550 ethnically matched controls from Madrid (Spain). Replication and meta-analysis with results from an independent cohort of 771 MS patients and 759 controls from Andalucía (Spain) confirmed the association of polymorphisms in the IL2RA gene (P(Mantel-Haenszel,) odds ratio (OR)(M-H) (95% confidence interval, CI) for rs2104286: 0.0001, 0.75 (0.65-0.87); for rs11594656/rs35285258: 0.004, 1.19 (1.06-1.34); for rs41295061: 0.03, 0.77 (0.60-0.98)); showed a trend for association of the IL2/IL21 rs6822844 (P(M-H)=0.07, OR(M-H) (95% CI)=0.86 (0.73-1.01)), but did not corroborate the association for IL2RB. Regression analyses of the combined Spanish cohort revealed the independence of two IL2RA association signals: rs2104286 and rs11594656/rs35285258. The relevant role of the IL2RA gene on MS susceptibility adds support to its common effect on autoimmune risk and the suggestive association of IL2/IL21 warrants further investigation.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-11525806, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-11791445, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-15067033, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-15343366, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-15753210, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-15776395, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17302889, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17371467, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17420929, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17554260, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17554300, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17558408, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17660530, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17676041, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17709711, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17936914, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-17999365, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-18178821, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-18285833, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-18354419, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-18369459, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-18565446, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-18663124, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-19119414, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-19125193, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-19286671, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-19364933, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-19523143, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-19631295, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-19701192, http://linkedlifedata.com/resource/pubmed/commentcorrection/20179739-6847134
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1476-5438
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
794-9
pubmed:dateRevised
2011-8-1
pubmed:meshHeading
pubmed-meshheading:20179739-Adolescent, pubmed-meshheading:20179739-Adult, pubmed-meshheading:20179739-Aged, pubmed-meshheading:20179739-Alleles, pubmed-meshheading:20179739-Case-Control Studies, pubmed-meshheading:20179739-Cohort Studies, pubmed-meshheading:20179739-Gene Frequency, pubmed-meshheading:20179739-Genetic Predisposition to Disease, pubmed-meshheading:20179739-Humans, pubmed-meshheading:20179739-Interleukin-2, pubmed-meshheading:20179739-Interleukin-2 Receptor alpha Subunit, pubmed-meshheading:20179739-Interleukin-2 Receptor beta Subunit, pubmed-meshheading:20179739-Linkage Disequilibrium, pubmed-meshheading:20179739-Logistic Models, pubmed-meshheading:20179739-Middle Aged, pubmed-meshheading:20179739-Multiple Sclerosis, pubmed-meshheading:20179739-Polymorphism, Single Nucleotide, pubmed-meshheading:20179739-Spain, pubmed-meshheading:20179739-Young Adult
pubmed:year
2010
pubmed:articleTitle
Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk.
pubmed:affiliation
Immunology Department, Hospital Clínico San Carlos, Madrid, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't